“A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS” (2018) Brazilian Journal of Pharmaceutical Sciences, 54(2), p. e17163. doi:10.1590/s2175-97902018000217163.